Gadoterate Meglumine contains not less than 97.0% and not more than 103.0% of C16H25GdN4O8•C7H17NO5, on anhydrous basis.

共有 1 個藥物證書使用此成份

"因華"釓四酸葡甲胺鹽
Gadoterate Meglumine "InnoPharmax"

• 申請商: 因華生技製藥股份有限公司
• 適應症: 顯影劑。
• 發證日期: 2021-07-28